Becker's Hospital Review

Non-ventilator hospital-acquired pneumonia: Are you addressing the hidden issue affecting more patients at a greater cost than VAP?

Each year, approximately 1.7 million healthcare-associated infections occur in U.S. hospitals, affecting 5 to 10 percent of the nation’s hospitalized patients annually, according to the Centers for ...
Monthly Prescribing Reference

Fetroja Approved for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia

The FDA has approved Fetroja® (cefiderocol; Shionogi) for the treatment of adult patients with HABP/VABP caused by susceptible Gram-negative pathogens. The Food and Drug Administration (FDA) has ...
Monthly Prescribing Reference

Three-Drug Combo Promising in Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia Study

Three-Drug Combo Promising in Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia Study Diana Ernst, RPh | October 1, 2019 ...
Health Affairs

Hospital-Acquired Pneumonia Threatens Patient Safety—Policy Makers Must Act To Confront It

Hospital-acquired pneumonia (HAP), which includes both nonventilator-associated pneumonia (NVHAP) and ventilator-associated pneumonia (VAP), is one of the most common health care-associated infections ...
Medscape

Can Gram Stains Guide Antibiotics for Pneumonia in Critical Care?

Similar outcomes in patients with ventilator-associated pneumonia (VAP) suggest that antibiotics selected by Gram staining were noninferior to those based on guidelines and also significantly ...
News Medical

Health care leaders call for action to prevent non-ventilator-associated, hospital-acquired pneumonia

A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired ...